TITLE

Radiofrequency Ablation of Recurrent Cholangiocarcinoma

AUTHOR(S)
Slakey, Douglas P.
PUB. DATE
April 2002
SOURCE
American Surgeon;Apr2002, Vol. 68 Issue 4, p395
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Intrahepatic recurrence of cholangiocarcinoma after primary resection has traditionally been considered a contraindication to surgical management. Improvements in ablative technologies such as radiofrequency ablation (RFA) offer the surgeon additional alternatives in the management of selected intrahepatic tumors. We present a case report of a single intrahepatic recurrence of cholangiocarcinoma 12 months after primary resection of extrahepatic cholangiocarcinoma including right lobectomy for intrahepatic extension. The patient received operative treatment and RFA of the intrahepatic lesion. RFA successfully ablated the recurrent tumor, and the patient remains free of detectable disease 10 months later. A review of literature is presented. This is the first known report of the use of RFA for intrahepatic cholangiocarcinoma. In selected cases of primary or recurrent cholangiocarcinoma, RFA may increase the percentage of patients considered surgically treatable.
ACCESSION #
6596577

 

Related Articles

  • Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. Young, Alastair; Prasad, K.; Toogood, Giles; Lodge, J. // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jul2010, Vol. 17 Issue 4, p497 

    Objective: Surgery for hilar cholangiocarcinoma (HCCA) remains challenging, with radical procedures thought to offer the best chance of long-term survival. Here we present our data for surgical resection of HCCA for the period 2001-2008. Methods: A prospectively maintained database was...

  • Is an aggressive surgical approach worthwhile in biliary cancer? Ristagno, Nadja; Knuth, Alexander; Pestalozzi, Bernhard C. // International Seminars in Surgical Oncology;2007, Vol. 4, p26 

    Background: Biliary cancer includes cancer of the gallbladder as well as extrahepatic and intrahepatic cholangiocarcinoma. Surgery is the only curative treatment option available. Recently, much more aggressive surgical approaches have been employed. Therefore, we have investigated outcome of...

  • A Review and Update on Cholangiocarcinoma. Olnes, Matthew J.; Erlich, Rodrigo // Oncology;2004, Vol. 66 Issue 3, p167 

    Cholangiocarcinoma is a malignant neoplasm arising from the biliary epithelium that was first described by Durand-Fardel in 1840. Today, it continues to defy diagnosis and treatment. It is difficult to diagnose in part because of its relative rarity, and because it is clinically silent until it...

  • Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma. RAMACCIATO, GIOVANNI; NIGRI, GIUSEPPE; BELLAGAMBA, RICCARDO; PETRUCCIANI, NICCOLĂ’; RAVAIOLI, MATTEO; CESCON, MATTEO; DEL GAUDIO, MASSIMO; ERCOLANI, GIORGIO; DI BENEDETTO, FABRIZIO; CAUTERO, NICOLA; QUINTINI, CRISTIANO; CUCCHETTI, ALESSANDRO; LAURO, AUGUSTO; MILLER, CHARLES; PINNA, ANTONIO DANIELE // American Surgeon;Nov2010, Vol. 76 Issue 11, p1260 

    Surgery is the only effective treatment able to improve survival of patients with hilar cholangiocarcinoma (CCA). However, the significance of prognostic factors on overall survival is still debated. We evaluated early and long-term outcomes of patients resected for hilar cholangiocarcinoma over...

  • Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. Rocha, Flavio; Matsuo, Kenichi; Blumgart, Leslie; Jarnagin, William // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jul2010, Vol. 17 Issue 4, p490 

    Background/purpose: Hilar cholangiocarcinoma (HCCA) is a rare cancer with a low resectability rate, frequent recurrence after resection and an overall poor outcome. It is widely accepted that en bloc partial hepatectomy is a necessary part of the surgical therapy, but controversy surrounds other...

  • Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. Lee, Sung; Song, Gi; Hwang, Shin; Ha, Tae; Moon, Deok; Jung, Dong; Kim, Ki; Ahn, Chul; Kim, Myung; Sung, Kyu; Ko, Gi // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jul2010, Vol. 17 Issue 4, p476 

    Background/purpose: Both curative resection and minimized in-hospital mortality offer the only chance of long-term survival in patients with hilar cholangiocarcinoma. The reported resectability rates for hilar cholangiocarcinoma have increased by virtue of combined major hepatectomy, but this...

  • Laparoscopic fenestration of multiple giant biliary mucinous cystadenomas of the liver. Manouras, A.; Lagoudianakis, E.; Alevizos, L.; Markogiannakis, H.; Kafiri, G.; Bramis, C.; Filis, K.; Toutouzas, K. // World Journal of Gastroenterology;7/14/2008, Vol. 14 Issue 26, p4257 

    Biliary cystadenomas of the liver are rare, cystic neoplasms of the biliary ductal system usually occur in middle aged women. We report a case of synchronous multiple huge biliary mucinous cystadenomas with unique features. This is, according to our knowledge, the first report in the literature...

  • A New Clinically Based Staging System for Perihilar Cholangiocarcinoma. Chaiteerakij, Roongruedee; Harmsen, William S; Marrero, Carlos Romero; Aboelsoud, Mohammed M.; Ndzengue, Albert; Kaiya, Joseph; Therneau, Terry M; Sanchez, William; Gores, Gregory J; Roberts, Lewis R // American Journal of Gastroenterology;Dec2014, Vol. 109 Issue 12, p1881 

    OBJECTIVES:Current staging systems for perihilar cholangiocarcinoma (pCCA) are inadequate, as they are based on surgical pathology and therefore not relevant to unresectable patients. Clinical trials for potential targeted therapies for pCCA are hampered by the lack of an accurate, nonoperative...

  • COLORECTAL NEOPLASIA - III: TREATMENT AND PREVENTION. Schofield, P.F.; Jones, D.J. // BMJ: British Medical Journal (International Edition);6/20/92, Vol. 304 Issue 6842, p1624 

    Examines the treatment and prevention of colorectal neoplasia. Excision of the left colon by hemicolectomy; Resection of secondary tumors on the liver; Justification of colostomy in the absence of obstruction.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics